Budesonide Nebulisation in Children
Primary Indications
- Nebulised budesonide (500 μg) may reduce symptoms in croup in the first two hours, according to the Thorax journal 1, 2
- Uncontrolled data suggest inhaled steroids may improve lung mechanics and short-term outcomes in neonates with bronchopulmonary dysplasia (BPD), as reported in the Thorax journal 1, 3
Dosing Recommendations
- For viral-induced wheeze in children under 4 years, maintenance therapy with 0.25-0.5 mg twice daily of budesonide nebulisation is recommended, as suggested by Praxis Medical Insights 4
- For croup, 500 μg of budesonide nebulisation as a single dose or repeated dose may be effective, according to the Thorax journal 1, 2
Administration Considerations
- For children under 4 years, budesonide nebulisation requires a face mask that should fit snugly over nose and mouth, as recommended by Praxis Medical Insights 5
- Budesonide suspension is compatible with albuterol, ipratropium, and levalbuterol nebulizer solutions in the same nebulizer, as reported by Praxis Medical Insights 5
Clinical Approach to Therapy
- Assess asthma severity and control before initiating therapy, as suggested by Praxis Medical Insights 6
- If no clear benefit is observed within 4-6 weeks, consider alternative therapies or diagnoses, as recommended by Praxis Medical Insights 5
- For recurrent wheezing triggered by respiratory infections, consider intermittent high-dose therapy, as suggested by Praxis Medical Insights 4